1
|
Li Y, Li F. Mechanism and Prospect of Gastrodin in Osteoporosis, Bone Regeneration, and Osseointegration. Pharmaceuticals (Basel) 2022; 15:1432. [PMID: 36422561 PMCID: PMC9698149 DOI: 10.3390/ph15111432] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 11/08/2022] [Accepted: 11/16/2022] [Indexed: 11/14/2023] Open
Abstract
Gastrodin, a traditional Chinese medicine ingredient, is widely used to treat vascular and neurological diseases. However, recently, an increasing number of studies have shown that gastrodin has anti-osteoporosis effects, and its mechanisms of action include its antioxidant effect, anti-inflammatory effect, and anti-apoptotic effect. In addition, gastrodin has many unique advantages in promoting bone healing in tissue engineering, such as inducing high hydrophilicity in the material surface, its anti-inflammatory effect, and pro-vascular regeneration. Therefore, this paper summarized the effects and mechanisms of gastrodin on osteoporosis and bone regeneration in the current research. Here we propose an assumption that the use of gastrodin in the surface loading of oral implants may greatly promote the osseointegration of implants and increase the success rate of implants. In addition, we speculated on the potential mechanisms of gastrodin against osteoporosis, by affecting actin filament polymerization, renin-angiotensin system (RAS) and ferroptosis, and proposed that the potential combination of gastrodin with Mg2+, angiotensin type 2 receptor blockers or artemisinin may greatly inhibit osteoporosis. The purpose of this review is to provide a reference for more in-depth research and application of gastrodin in the treatment of osteoporosis and implant osseointegration in the future.
Collapse
Affiliation(s)
| | - Fenglan Li
- Department of Prosthodontics, Shanxi Provincial People’s Hospital, Shanxi Medical University, Taiyuan 030000, China
| |
Collapse
|
2
|
Cheng H, Wang XB, Zhi Y, Liu B, Liu N, Li MJ, Mu YL. A Pyridazinone Compound for Effectively Treating Non-alcoholic Steatohepatitis by Targeting THRβ. Front Chem 2022; 10:888587. [PMID: 35620649 PMCID: PMC9127185 DOI: 10.3389/fchem.2022.888587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Accepted: 03/17/2022] [Indexed: 11/23/2022] Open
Abstract
Developing effective therapies and medicines to conquer nonalcoholic steatohepatitis (NASH) is of great significance for public health and is faced with a major challenge. The activation of the thyroid hormone receptor agonist THRβ could be regulated by target drugs that has brought huge potential to the treatment of NASH. In this work, pyridazinone compound YWS01125 was synthesized for the first time. In this study, an ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS) method for YWS01125 determination was established, and the pharmacokinetics of YWS01125 was evaluated. The half-life values (t1/2)of three different doses of YWS01125 was 189.12 ± 95.27, 152.64 ± 37.98, and 181.95 ± 64.25 min, respectively, and the tissue distribution studies demonstrated that YWS01125 was quickly distributed to various tissues. With successful application in the pharmacokinetics study of YWS01125, the UPLC-MS/MS method has shown characteristics of high sensitivity, rapidity, and good selectivity.
Collapse
Affiliation(s)
- Hao Cheng
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China
- Key Laboratory for Biotech-Drugs Ministry of Health, Jinan, China
- Key Laboratory for RareUncommon Diseases of Shandong Province, Jinan, China
| | - Xiao-Bo Wang
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China
- Key Laboratory for RareUncommon Diseases of Shandong Province, Jinan, China
| | - Ying Zhi
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China
- Key Laboratory for Biotech-Drugs Ministry of Health, Jinan, China
- Key Laboratory for RareUncommon Diseases of Shandong Province, Jinan, China
| | - Bo Liu
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China
- Key Laboratory for Biotech-Drugs Ministry of Health, Jinan, China
- Key Laboratory for RareUncommon Diseases of Shandong Province, Jinan, China
| | - Na Liu
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
| | - Meng-Jun Li
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
| | - Yan-Ling Mu
- School of Pharmacy and Pharmaceutical Sciences, Shandong First Medical University, Jinan, China
- Institute of Materia Medica, Shandong Academy of Medical Sciences, Jinan, China
- Key Laboratory for Biotech-Drugs Ministry of Health, Jinan, China
- Key Laboratory for RareUncommon Diseases of Shandong Province, Jinan, China
- *Correspondence: Yan-Ling Mu,
| |
Collapse
|
3
|
Classical Active Ingredients and Extracts of Chinese Herbal Medicines: Pharmacokinetics, Pharmacodynamics, and Molecular Mechanisms for Ischemic Stroke. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY 2021; 2021:8868941. [PMID: 33791075 PMCID: PMC7984881 DOI: 10.1155/2021/8868941] [Citation(s) in RCA: 63] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Revised: 01/08/2021] [Accepted: 02/28/2021] [Indexed: 12/17/2022]
Abstract
Stroke is a leading cause of death and disability worldwide, and approximately 87% of cases are attributed to ischemia. The main factors that cause ischemic stroke include excitotoxicity, energy metabolism disorder, Ca+ overload, oxidative damage, apoptosis, autophagy, and inflammation. However, no effective drug is currently available for the comprehensive treatment of ischemic stroke in clinical applications; thus, there is an urgent need to find and develop comprehensive and effective drugs to treat postischemic stroke. Traditional Chinese medicine (TCM) has unique advantages in treating ischemic stroke, with overall regulatory effects at multiple levels and on multiple targets. Many researchers have studied the effective components of TCMs and have achieved undeniable results. This paper reviews studies on the anticerebral ischemia effects of TCM monomers such as tetramethylpyrazine (TMP), dl-3-n-butylphthalide (NBP), ginsenoside Rg1 (Rg1), tanshinone IIA (TSA), gastrodin (Gas), and baicalin (BA) as well as effective extracts such as Ginkgo biloba extract (EGB). Research on the anticerebral ischemia effects of TCMs has focused mostly on their antioxidative stress, antiapoptotic, anti-inflammatory, proangiogenic, and proneurogenic effects. However, the research on the use of TCM to treat ischemic stroke remains incompletely characterized. Thus, we summarized and considered this topic from the perspective of pharmacokinetics, pharmacological effects, and mechanistic research, and we have provided a reference basis for future research and development on anticerebral ischemia TCM drugs.
Collapse
|
4
|
Dong J, Ji D, Su L, Zhang F, Tong H, Mao C, Lu T. A simplified LC−MS/MS approach for simultaneous quantification and pharmacokinetics of five compounds in rats following oral administration of Gastrodia elata extract. J Anal Sci Technol 2020. [DOI: 10.1186/s40543-020-00211-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
Abstract
Background
To support the multicomponent pharmacokinetics of Gastrodia elata, a rapid, simple, and sensitive ultra-performance liquid chromatography tandem with mass spectrometry (LC–MS/MS) approach was established for simultaneous quantification of gastrodin, parishin A, parishin B, parishin C, and parishin E.
Methods
Five compounds were extracted from plasma by using one-step protein precipitation. The chromatographic separation was achieved on a C18 column with gradient mobile phase comprising acetonitrile and 0.05% formic acid. The detection was performed using negative electrospray ionization in multiple reaction monitoring mode.
Results
This new method maximizes assay throughput by using minimal sample clean-up procedures and a shorter analytical run time. The approach exhibited good linearity for the five compounds (r2 > 0.995) in the concentration ranges. The lower limits of quantification (LLOQ) were determined as 1.37 ng/mL for parishin A, parishin B, parishin C, and parishin E and 10 ng/mL for gastrodin. Then the method was fully validated with intra- and inter-day precision, accuracy, matrix effects, extraction recovery, and stability.
Conclusion
This validated approach was successfully applied to the pharmacokinetic study following oral administration of Gastrodia elata extract to rats. This investigation may provide some guidance for the clinical application and explanation of the pharmacological mechanism of Gastrodia elata.
Collapse
|
5
|
Zhou C, He M, Peng C, Yu J, Li Z, Zhou M, Li Y, Yang S, Ouyang H, Feng Y. Pharmacokinetic and Lipidomic Assessment of the In Vivo Effects of Parishin A-Isorhynchophylline in Rat Migraine Models. JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY 2020; 2020:9101598. [PMID: 32695549 PMCID: PMC7362284 DOI: 10.1155/2020/9101598] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Accepted: 03/27/2020] [Indexed: 06/11/2023]
Abstract
Migraine is a chronic brain disease that leads to periodic neurological attacks. Parishin A and isorhynchophylline (PI) is the active monomer component extracted from the traditional antimigraine Chinese medicinal combination of Gastrodia and Uncaria, respectively. In this study, using high-performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS/MS) technology, we performed pharmacokinetic and lipidomic study on migraine model rats after administration of PI. For the detection of the compounds in plasma, AB Sciex Triple Quad™ 4500 was applied for quantitative analysis, and the COSMOSIL C18 column (2.1 × 100 mm, 2.6 μm) was used for separation. Isorhynchophylline (ISO: m/z 384.8-241.2) and its main metabolite rhynchophylline (RHY: m/z 384.8-160.2) were simultaneously detected under positive ion modes. Besides, parishin A (PA: m/z 995.1-726.9) and its main metabolite gastrodin (GAS: m/z 331.1-123.0) were simultaneously detected with negative ion modes. For the analysis of endogenous lipid components, Dionex Ultimate 3000 (UHPLC) Thermo Orbitrap Elite was applied for the detection, and the Waters UPLCRBEH C18 column (1.7 μm 100 ∗ 2.1 mm) was used for separation. Chloroform/methanol (2 : 1, v : v) was used for extraction. The results demonstrated that PI exists significant difference in metabolism between single- and coadministration and can regulate lipid levels associated with migraine.
Collapse
Affiliation(s)
- Chaoqun Zhou
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Mingzhen He
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Nanchang, China
| | - Chunyan Peng
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Jianjun Yu
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Zhifeng Li
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Nanchang, China
| | - Maofu Zhou
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Yan Li
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Shilin Yang
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Nanchang, China
| | - Hui Ouyang
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
| | - Yulin Feng
- Jiangxi University of Traditional Chinese Medicine, Nanchang, China
- State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Nanchang, China
| |
Collapse
|
6
|
Zuo Y, Deng X, Wu Q. Discrimination of Gastrodia elata from Different Geographical Origin for Quality Evaluation Using Newly-Build Near Infrared Spectrum Coupled with Multivariate Analysis. Molecules 2018; 23:molecules23051088. [PMID: 29734695 PMCID: PMC6100057 DOI: 10.3390/molecules23051088] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2018] [Revised: 04/30/2018] [Accepted: 05/02/2018] [Indexed: 12/30/2022] Open
Abstract
Discrimination of Gastrodia elata (G. elata) geographical origin is of great importance to pharmaceutical companies and consumers in China. this paper focuses on the feasibility of near infrared spectrum (NIRS) combined multivariate analysis as a rapid and non-destructive method to prove its fit for this purpose. Firstly, 16 batches of G. elata samples from four main-cultivation regions in China were quantified by traditional HPLC method. It showed that samples from different origins could not be efficiently differentiated by the contents of four phenolic compounds in this study. Secondly, the raw near infrared (NIR) spectra of those samples were acquired and two different pattern recognition techniques were used to classify the geographical origins. The results showed that with spectral transformation optimized, discriminant analysis (DA) provided 97% and 99% correct classification for the calibration and validation sets of samples from discriminating of four different main-cultivation regions, and provided 98% and 99% correct classifications for the calibration and validation sets of samples from eight different cities, respectively, which all performed better than the principal component analysis (PCA) method. Thirdly, as phenolic compounds content (PCC) is highly related with the quality of G. elata, synergy interval partial least squares (Si-PLS) was applied to build the PCC prediction model. The coefficient of determination for prediction (Rp2) of the Si-PLS model was 0.9209, and root mean square error for prediction (RMSEP) was 0.338. The two regions (4800 cm−1–5200 cm−1, and 5600 cm−1–6000 cm−1) selected by Si-PLS corresponded to the absorptions of aromatic ring in the basic phenolic structure. It can be concluded that NIR spectroscopy combined with PCA, DA and Si-PLS would be a potential tool to provide a reference for the quality control of G. elata.
Collapse
Affiliation(s)
- Yamin Zuo
- Guizhou Key Laboratory for Information System of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, 116 Baoshan North Rd, Guiyang 550001, Guizhou, China.
- School of Basic Medical Sciences, Hubei University of Medicine, 30 Renmin South Rd, Shiyan 442000, Hubei, China.
| | - Xuehua Deng
- School of Pharmacy, Hubei University of Medicine, 30 Renmin South Rd, Shiyan 442000, Hubei, China.
| | - Qing Wu
- Guizhou Key Laboratory for Information System of Mountainous Areas and Protection of Ecological Environment, Guizhou Normal University, 116 Baoshan North Rd, Guiyang 550001, Guizhou, China.
- Innovation Laboratory, the Third Experiment Middle School in Guiyang, Guiyang 550001, Guizhou, China.
| |
Collapse
|
7
|
Liu J, Chen S, Cheng J, Zhang J, Wang Y, Liu A. An Optimized and Sensitive Pharmacokinetic Quantitative Method of Investigating Gastrodin, Parishin, and Parishin B, C and E in Beagle Dog Plasma using LC-MS/MS after Intragastric Administration of Tall Gastrodia Capsules. Molecules 2017; 22:molecules22111938. [PMID: 29125575 PMCID: PMC6150220 DOI: 10.3390/molecules22111938] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 11/06/2017] [Accepted: 11/07/2017] [Indexed: 11/16/2022] Open
Abstract
Gastrodia elata Blume, called Tianma in China, has been widely used to treat headaches, convulsions and epilepsy for thousands of years. In the present study, a series of optimizations were employed to develop a rapid, sensitive, and reliable high-performance liquid chromatography-triple quadrupole mass spectrometry method, which was then used for the simultaneous determination of gastrodin, parishin, parishin B, parishin C and parishin E in beagle dog plasma after intragastric administration of tall Gastrodia capsules (Tianma brand). The chromatographic separation was achieved on a C18 column with gradient elution by using a mixture of 0.4% formic acid aqueous solution and acetonitrile as the mobile phase at a flow rate of 0.15 mL/min. A tandem mass spectrometric detection was conducted using multiple-reaction monitoring (MRM) via electrospray ionization (ESI) source in negative ionization mode. Samples were pre-treated by a single-step protein precipitation with methanol, and bergenin was used as internal standard (IS). Under the optimized conditions, the lower limit of quantification (LLOQ) was 0.10 ng/mL for gastrodin, 0.40 ng/mL for parishin B, 0.02 ng/mL for parishin E and 0.20 ng/mL for parishin and parishin C, all of which previously were the highest levels of sensitivity. The methods were optimized for selectivity, calibration curves, accuracy and precision. Extraction recoveries, matrix effects and stability were within acceptable ranges. Pharmacokinetic parameters of the tested substances were also quantitatively determined. Finally, a possible metabolic pathway was induced based on correlations obtained from quantitative and qualitative data analysis in vivo.
Collapse
Affiliation(s)
- Junqiu Liu
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| | - Sha Chen
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| | - Jintang Cheng
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| | - Jun Zhang
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| | - Yuesheng Wang
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| | - An Liu
- Key laboratory of Beijing for identification and safety evaluation of Chinese medicine, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, No. 16, Nanxiaojie, Dongzhimennei, Beijing 100700, China.
| |
Collapse
|